Karuna Therapeutics Q3 EPS $(0.39)

Karuna Therapeutics (NASDAQ:KRTX) reported quarterly losses of $(0.39) per share.

Benzinga · 11/07/2019 11:40

Karuna Therapeutics (NASDAQ:KRTX) reported quarterly losses of $(0.39) per share.